Literature DB >> 726964

Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate.

M Sonobe, J Suzuki.   

Abstract

Fresh blood and supernatants of blood-CSF mixtures incubated for 1 to 15 days were applied to the basilar artery of adult cats, and the degree of constriction was measured with a surgical microscope. The constriction due to fresh blood was weak and transient. It seems possible to assume that serotonin isolated from platelets participates greatly in the transient vasoconstriction induced by fresh blood. Supernatants of blood-CSF mixtures incubated for three days had weak activity in comparison with the powerful and long-lasting activity of those incubated for seven days. Furthermore, mixtures incubated for 15 days had little or no activity. This change in the vasoconstrictive activity was similar to, and coincides chronologically with clinical late spasm following subarachnoid haemorrhage 34. We investigated the vasospasmogenic substance in the seventh day mixture. Heat coagulation, ultrafiltration, sephadex G-100 gel-chromatography, disc-electrophoresis, and Spectrophotography show that extracellular oxyHb has a strong spasmogenic activity. In the 15th day mixture, oxyHb is spontaneously converted to metHb. Experimentally, oxyHb has a strong vasoconstrictive activity, and metHb has no vasoconstrictive activity. We have had success in oxidizing oxyHb into metHb with sodium nitrite, thus preventing experimental vasospasm.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 726964     DOI: 10.1007/bf01401633

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  31 in total

1.  Experimental study on the genesis of cerebral vasospasm.

Authors:  R P White; A A Hagen; H Morgan; W N Dawson; J T Robertson
Journal:  Stroke       Date:  1975 Jan-Feb       Impact factor: 7.914

2.  Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries.

Authors:  G S Allen; L M Henderson; S N Chou; L A French
Journal:  J Neurosurg       Date:  1974-04       Impact factor: 5.115

3.  [Experimental studies on cerebral vasospasm--with special attention to the neurogenic factor (author's transl)].

Authors:  R Kimura
Journal:  Nihon Geka Hokan       Date:  1973-10

4.  Prolonged cerebral vasospasm in experimental subarachnoid hemorrhage.

Authors:  B Landau; J Ransohoff
Journal:  Neurology       Date:  1968-11       Impact factor: 9.910

5.  Cerebral vasospasm induced by subarachnoid blood and serotonin. An angiographic study.

Authors:  R W Chow; T H Newton; M C Smith; J E Adams
Journal:  Invest Radiol       Date:  1968 Nov-Dec       Impact factor: 6.016

6.  Cerebral arterial spasm. 1. Evaluation of experimental variables affecting the diameteor of the exposed basilar artery.

Authors:  J Kapp; M S Mahaley; G L Odom
Journal:  J Neurosurg       Date:  1968-10       Impact factor: 5.115

7.  Intracranial arterial spasm in the dog. A chronic experimental model.

Authors:  R H Wilkins; P Levitt
Journal:  J Neurosurg       Date:  1970-09       Impact factor: 5.115

8.  [Etiology and treatment of prolonged vasospasm --experimental and clinical studies-- (author's transl)].

Authors:  M Miyaoka; T Nonaka; H Watanabe; H Chigasaki; S Ishi
Journal:  Neurol Med Chir (Tokyo)       Date:  1976-03       Impact factor: 1.742

9.  [Experimental cerebral vasospasm after subarachnoid hemorrhage --course and degree of vasospasm-- (author's transl)].

Authors:  S Endo; J Suzuki
Journal:  Neurol Med Chir (Tokyo)       Date:  1977-01       Impact factor: 1.742

10.  Experimental cerebral vasospasm. Part 2: effects of vasoactive drugs and sympathectomy on early and late spasm.

Authors:  H Nagai; S Noda; H Mabe
Journal:  J Neurosurg       Date:  1975-04       Impact factor: 5.115

View more
  10 in total

Review 1.  Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology.

Authors:  Jacob Hansen-Schwartz
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Ultraearly surgery of intracranial aneurysms.

Authors:  J Suzuki; N Kodama; T Yoshimoto; K Mizoi
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  The Reemergence of Nitrite as a Beneficial Agent in the Treatment of Ischemic Cardiovascular Diseases.

Authors:  Bobby D Nossaman; Haseeb A Akuly; George F Lasker; Vaughn E Nossaman; Philip A Rothberg; Philip J Kadowitz
Journal:  Asian J Exp Biol Sci       Date:  2010-04

4.  The effect of prostacyclin on cerebral vasospasm. An experimental study.

Authors:  L Quintana; R Konda; Y Ishibashi; T Yoshimoto; J Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  Relation of cerebral vasospasm to operative findings of subarachnoid blood around ruptured aneurysms.

Authors:  F Tomasello; V Albanese; P Picozzi; A Spadaro; P Conforti
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage.

Authors:  J Suzuki; S Komatsu; T Sato; Y Sakurai
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

7.  Haem derivatives in subdural haematomas.

Authors:  N G Wahlgren; C Lindquist
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 8.  Cerebral vasospasm as a complication of aneurysmal subarachnoid hemorrhage: a brief review.

Authors:  A Spallone
Journal:  Ital J Neurol Sci       Date:  1985-03

9.  Vasoconstriction of external carotid arteries after rupture of intracranial aneurysms.

Authors:  S Endo; S Hori; J Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

Review 10.  Role of platelets in the pathogenesis of delayed injury after subarachnoid hemorrhage.

Authors:  Ari Dienel; Peeyush Kumar T; Spiros L Blackburn; Devin W McBride
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-10       Impact factor: 6.960

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.